8-K
Current Report
Taysha Gene Therapies, Inc. Filed Acc 0001193125-20-285213
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading d202550d8k.htm…
Taysha Gene Therapies, Inc. Filed Acc 0001193125-20-285213
Material agreement
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…